Supernus Pharmaceuticals (SUPN) Q4 2013 Earnings

12NovConfirmed
Mar 13
May 13
Q3 2013
Q4 2013
-0.71
-0.64
-0.58
-0.51

Details

Expected EPS
N/A
Actual EPS
-0.64
Surprise EPS
-0.64
Surprise Percent
+∞%

Description

Supernus Pharmaceuticals (SUPN) has reported earnings of -0.64 per share for Q4 2013.

0 Comments

Share your thoughts